Natural Breast Enlargement Treatment
Flat To Flab Breast Enlargement Program
First Things First:
Implants have been used since 1895 to augment the size or shape of women's breasts . The earliest known implant was attempted by Czerny , using a woman's own adipose tissue (from a lipoma , a benign growth, on her back). Gersuny tried paraffin injections in 1889, with disastrous results. Subsequently, in the early to mid-1900s, a number of other substances were tried, including ivory, glass balls, ground rubber, ox cartilage, Terylene wool, gutta-percha , Dicora, polyethylene chips, polyvinyl alcohol-formaldehyde polymer sponge (Ivalon), Ivalon in a polyethylene sac, polyether foam sponge (Etheron), polyethylene tape (Polystan) or strips wound into a ball, polyester (polyurethane foam sponge) Silastic rubber, and teflon-silicone prostheses. In recent history, various creams and medicaments have been used in attempts to increase bust size, and Berson in 1945 and Maliniac in 1950 performed a flap-based augmentation by rotating the patients chest wall tissue into the breast to add volume. Various synthetics were used throughout the 1950s and 1960s, including silicone injections, which an estimated 50,000 women received. Development of silicone granulomas and hardening of the breasts were in some cases so severe that women needed to have mastectomies for treatment. Women sometimes seek medical treatment for complications up to 30 years after receiving this type of injection.
Indications
Clinical indications for the use of breast implants are for breast reconstruction , sex reassignment surgery , and for abnormalities that affect the shape and size of the breast. In some countries health insurers will reimburse insertion of breast implants only for these indications. Non-clinical indications (the most common reasons) are cosmetic.
Systemic illness and disease
Since the early 1990s, a number of independent systemic (comprehensive) reviews have examined studies concerning links between silicone gel breast implants and systemic diseases. The consensus of these reviews is that there is no clear evidence of a causal link between the implantation of silicone breast implants and systemic disease.
Thousands of women still claim that they have become ill from their implants. Complaints include neurological and rheumatological problems. Some studies have suggested that subjective and objective symptoms of women with implants may improve when their implants are removed.
As studies have followed women with implants for a longer period of time, more data has become available on systemic diseases as well as autoimmune symptoms. Several large studies from the national health registry in Denmark found implant recipients no more likely to be diagnosed with an increased incidence of classic auto-immune symptoms as compared to women of the same age in the general population, and that musculoskeletal symptoms were generally lower among women with implants compared with women with other cosmetic surgery and women in the general population. [23] . Recent longitudinal follow-up of these patients has confirmed previously reported findings.
Several studies have established that women who undergo breast augmentation or other plastic surgery tend to be healthier and more affluent than the general population, prior to surgery and afterwards. For example, two large studies of plastic surgery patients found a decreased standardized mortality ratio in both breast implant and other plastic surgery patients, but an increased risk of respiratory cancer deaths in breast implant recipients compared to other forms of plastic surgery. Smoking was statistically controlled in one study and not in the other, but the authors speculated that there could potentially be differences in smoking that might contribute to the higher lung cancer deaths among women with implants. ] Another large study with long-term follow-up of nearly 25,000 Canadian women with implants reported a 43 percent lower rate of breast cancer compared with the general population and a lower-than-average risk of developing cancer of any kind.
In 2001 a study suggested an increase in fibromyalgia among women with extracapsular silicone gel leakage, compared to women whose implants were not broken or leaking outside the capsule. This association has not repeated in a number of related studies, and the US-FDA concluded "the weight of the epidemiological evidence published in the literature does not support an association between fibromyalgia and breast implants."
While there is a general international consensus that silicone implants have not been shown to cause systemic illness, excluding the possibility that a small group of patients may become ill through (as yet) unknown mechanisms may prove difficult. As the US-FDA notes "researchers must study a large group of women without breast implants who are of similar age, health, and social status and who are followed for a long time (such as 10-20 years) before a relationship between breast implants and these diseases can conclusively be made."
Complications
Local complications that can occur with breast implants include post-operative bleeding ( hematoma ), fluid collections ( seroma ), surgical site infection, breast pain, alterations in nipple sensation, interference with breast feeding, visible wrinkling, asymmetric appearance, wound dehiscence (with potential implant exposure), thinning of the breast tissue, and synmastia (disruption of the natural plane between breasts).
Scarring
All surgical procedures on the breast leave scars. Scar quality is determined by factors including a patient's ethnicity, tissue quality, wound tension, suture material, tissue trauma from surgery, smoking, and an individuals propensity for favorable wound healing. While most breast augmentation incisions heal well, a rate of 6-7% of unfavorable scarring was reported for primary augmentation patients in US-FDA clinical trials.
Chronic pain and changes in nipple and breast sensitivity
Feeling in the nipple and breast can change after implant surgery. Changes include intense sensitivity, chronic breast pain, and no feeling in the nipple or breast for months or years after surgery.
In their booklets for patients, Allergan and Mentor report that within the first three years, between 2-8% of augmentation patients report moderate to severe chronic breast pain, an additional 1-2% report moderate to severe breast sensitivity changes, and 3-10% report moderate to severe nipple complications such as loss of sensation. [These are similar for silicone gel or saline breast implants, but the longer-term data on saline implants indicates that chronic breast pain is reported by 17% of women within five years.
This altered sensitivity can be temporary or permanent and may affect sexual response or the ability to nurse a baby.
Implant Extrusion and Tissue Necrosis
Compromise of blood supply as a result of surgical procedures may lead to skin loss or breast tissue necrosis (death). Unstable or weakened tissue covering may result in subsequent extrusion of the breast implant through the skin. Implant extrusion and tissue necrosis are rare in breast augmentation patients, but may occurs in up to 1-2% of reconstruction patients using implants.
Surgery needed to correct this can result in unacceptable scarring or breast tissue loss. Procedures which combine simultansous breast augmentation with mastopexy (breast lift) techniques carry higher rates of implant loss or wound breakdown then either procedure alone.
Platinum
Platinum is a catalyst used in the making of silicone implant polymer shells and other silicone devices used in medicine. The literature indicates that small amounts of platinum leaches (leaks) from these implants and is present in the surrounding tissue. The FDA reviewed the available studies from the medical literature on platinum and breast implants in 2002 and concluded there was little evidence suggesting toxicity from platinum in implant patients.
In 2006, researchers published a controversial study that claimed to identify the previously undocumented presence of toxic platinum oxidative states in vivo. A letter from the editors of the publishing journal, Analytical Chemistry , subsequently expressed concern over the research's experimental design and urged the journal's readers to "use caution in evaluating the conclusions drawn in the paper." The FDA reviewed this study and the existing literature, concluding that the body of existing research did not support their findings, and that the platinum in new implants is likely not ionized and therefore would not represent a significant risk to women.
Effective Alternative:
Flat To Flab Breast Enlargement Program
Some User Comments:
"When I started your program in October (4 months ago), my chest was 31". Today I am measuring in at 32 1/4". My breasts have filled out, too. They used to feel like two pieces of empty skin, but now it feels like there is actually something in there. I haven't told my husband what I'm doing, but the other day he actually asked if I was doing anything different because my breasts look bigger!"
CK, Pennsylvania
----
"I started "The Flat to Fab Breast Enlargement Program" in December of 2003. By the time I went on break at the end of May 2004, I had grown from a 32A/B to a small 32C! My beginning cup size was closer to an A, but I refused to buy that size due to having one breast larger than the other. My breasts are now the same size and I am sitting at a 32C and enjoying every minute of it! I am completely satisfied with my progress!"
KS,Indiana
----
"I would never have imagined that herbs and massage could do something about my breasts, but they have. I used to be a 34AA and I am now actually able to wear a real bra sized 34A. Since I am a dancer and very thin to begin with, I am satisfied with my overall growth. "The Flat to Fab Breast Enlargement Program" gave me the boost I wanted."
BL, London
Flat To Flab Breast Enlargement Program
